1. Home
  2. QUBT vs GENB Comparison

QUBT vs GENB Comparison

Compare QUBT & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum Computing Inc.

QUBT

Quantum Computing Inc.

N/A

Current Price

$6.86

Market Cap

1.7B

Sector

Technology

ML Signal

N/A

Logo Generate Biomedicines Inc. Common Stock

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$14.19

Market Cap

1.7B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
QUBT
GENB
Founded
2001
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2019
2026

Fundamental Metrics

Financial Performance
Metric
QUBT
GENB
Price
$6.86
$14.19
Analyst Decision
Buy
Strong Buy
Analyst Count
6
6
Target Price
$18.67
★ $27.00
AVG Volume (30 Days)
★ 6.4M
956.5K
Earning Date
11-09-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 84.93
N/A
EPS
★ N/A
N/A
Revenue
★ $682,000.00
N/A
Revenue This Year
$4,100.54
N/A
Revenue Next Year
$74.60
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 82.84
N/A
52 Week Low
$5.39
$11.00
52 Week High
$14.45
$22.67

Technical Indicators

Market Signals
Indicator
QUBT
GENB
Relative Strength Index (RSI) 49.62 51.96
Support Level $6.13 $11.82
Resistance Level $6.98 $14.29
Average True Range (ATR) 0.42 1.07
MACD 0.05 0.09
Stochastic Oscillator 91.28 46.71

Price Performance

Historical Comparison
QUBT
GENB

About QUBT Quantum Computing Inc.

Quantum Computing Inc is an integrated photonics and non-linear quantum optics company to develop and deliver machines for quantum computing, reservoir computing, and remote sensing, imaging, and cybersecurity applications based on patented and proprietary photonics technology. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offers capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: